Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.41 |
| ▸ | TNKS | O95271 | 2/20 | 0.37 |
| ▸ | TDP2 | O95551 | 2/20 | 0.35 |
| ▸ | KDR | P35968 | 1/20 | 0.34 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.34 |
| ▸ | RAF1 | P04049 | 1/20 | 0.34 |
| ▸ | PIM1 | P11309 | 1/20 | 0.33 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.33 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.33 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13965893 | 0.89 | PDK2 (0.35) | PDK2 | |
| SCHEMBL13965873 | 0.88 | PDK2 (0.36) | PDK2 | |
| SCHEMBL13965872 | 0.88 | TOP1 (0.33) | PDK2 | |
| SCHEMBL13965884 | 0.87 | KDM4E (0.33) | — | |
| SCHEMBL13965929 | 0.85 | PDK2 (0.31) | PDK2 | |
| SCHEMBL13965918 | 0.85 | PDK2 (0.39) | PDK2TNKSTDP2KDRCYP1A2 | |
| SCHEMBL13965959 | 0.84 | TOP1 (0.32) | PDK2 | |
| SCHEMBL13965874 | 0.82 | PGR (0.31) | PDK2GRM5 | |
| SCHEMBL13974892 | 0.82 | CYP11B2 (0.39) | MAPK1CYP19A1CYP11B1CYP11B2CYP17A1 | |
| SCHEMBL13965890 | 0.82 | KDM4E (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120292603-A1 | Heterocyclic compound, organic light-emitting device including the heterocyclic compound, and flat display device including the organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2012-11-22 | — | — | US | disclosed |
| US-20120292603-A1 | Heterocyclic compound, organic light-emitting device including the heterocyclic compound, and flat display device including the organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2012-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120292603-A1 | Heterocyclic compound, organic light-emitting device including the heterocyclic compound, and flat display device including the organic light-emitting device | DDT, SUN2, CYP1B1 | PDK2 337/4885TNKS 1893/4885TDP2 2275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.